ロード中...
How to Assess Founder Effect in Patients with Congenital Factor XIII Deficiency
Congenital factor XIII (FXIII) deficiency is an extremely rare bleeding disorder (RBD) with estimated prevalence of one per 2 million in the general population. The disorder causes different clinical manifestations such as intracranial hemorrhage (ICH), recurrent miscarriage, umbilical cord bleeding...
保存先:
| 出版年: | Int J Hematol Oncol Stem Cell Res |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7876424/ https://ncbi.nlm.nih.gov/pubmed/33603988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18502/ijhoscr.v14i4.4480 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|